Signs point to a cooling on the FDA's fiery approval pace of 2017, but 2018 has already seen five novel drug approvals.
The legalization of marijuana has consequences.
Managing the overall risk of medication therapy is more effective than simply managing drug-drug interactions.
Easy-to-swallow news and studies for the busy pharmacist.
The Advisory Committee on Immunization Practices now recommends use of Shingrix for adults aged 50 and over.
Lidocaine and capsaicin patches are effective for postherpetic neuralgia.
Zinbryta was taken off the market, leaving many patients with poor options.
It's something every pharmacist knows well—the long shift. Here's how to make it a little more bearable.
Amazon quietly rolled out a line of OTC products—and that should scare you.
On “School Exclusion Day” in Oregon kids without the required vaccines are sent home.